Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The fragmentation of corticotrophin-(1--24)-tetracosapeptide in vivo has been studied, using tritium-labelled hormone and chromatography, in the rat. After intravenous injection the levels of peptide in the circulation declined rapidly caused by its distribution to the tissues and from 2 min after injection a range of different cleavage products appeared. Many of the fragments in the circulation after 2 min have been identified and in this way cleavage has been shown to occur after residues 1, 2, 8, 15, 16, 17, 19, 20 and 21. It is believed that this is the result of aminopeptidase attack at the
NH2
terminal, and of attack on the basic region of the molecule by trypsin-like
endopeptidase
followed by carboxypeptidase. The sulphoxide has been identified as a major metabolite in some experiments but the extent of its formation was very variable. Seventy per cent of the dose was distributed to the tissue beds by 1 min. Part of this was present, mainly as intact peptide, in liver and kidney but the greater proportion was found in muscle, skin and intestine where extensive degradation had already occurred. Further characterization of the fragments formed in the muscle provided good evidence that this tissue may have been the site of generation of many of the fragments which later appeared in the circulation.
...
PMID:Mechanisms of catabolism of corticotrophin-(1--24)-tetracosapeptide in the rat in vivo. 624 13
The biotransformation of adrenocorticotropin (ACTH-(1-39)) by brain synaptic membranes has been studied. Peptide fragments of ACTH-(1-39) which were formed during in vitro incubation of the peptide with membrane preparations were isolated by high pressure liquid chromatography and characterized by determination of amino acid composition and
NH2
- terminal residue. At pH 7.4, ACTH-(1-38) was found as the main metabolite, together with ACTH-(7-21) and ACTH-(7-20). In addition, a series of secondary products was identified. At pH 6.2, ACTH-(1-38), ACTH-(1-37), and ACTH-(1-36) were exclusively formed, while at pH 8.5, ACTH-(1-39) was converted into ACTH-(1-16), ACTH-(17-39), ACTH-(22-39), and ACTH-(3-15). Time course experiments demonstrated the action of a carboxypeptidase activity and a trypsin-like
endopeptidase
on ACTH-(1-39) as predominant proteolytic events. The carboxypeptidase was optimally active at pH values of 5.7 or below. These enzymes play an essential role in the stepwise conversion of ACTH-(1-39) in brain. It is suggested that they are involved in the modulation of the central activities of ACTH fragments in the brain.
...
PMID:Proteolysis of adrenocorticotropin in brain. Characterization of cleavage sites by peptidases in synaptic membranes and formation of peptide fragments. 630 63
Three distinct peptidyldipeptidases (exopeptidases releasing carboxyl terminal dipeptide residues) can be solubilized from nerve terminal membrane fractions from whole rat brain or striatum, and separated by ion exchange chromatography. Brain angiotensin-converting enzyme (PDP-1) cleaves Hip-His-Leu, but not 80 nM [3H-Tyr1, Leu5]-enkephalin, and is markedly inhibited by several specific inhibitors such as captopril, teprotide, and MK-422. Enkephalinase (PDP-2) cleaves 80 nM [3H-Tyr1, Leu5]-enkephalin, but not Hip-His-Leu; it is not inhibited by any of the standard competitive inhibitors of angiotensin-converting enzyme (all analogs of carboxyl-terminal peptide sequences Phe-Ala-Pro or Ala-Pro), but is strongly inhibited by captopril analogs such as thiorphan (Phe-Gly analog). A third peptidyldipeptidase (PDP-3) cleaves Hip-His-Leu, but not 80 nM [3H-Tyr1, Leu5]-enkephalin; it is inhibited by dipeptide analog inhibitors such as captopril and thiorphan, but not by longer peptides such as teprotide or tripeptide analog inhibitors such as MK-422. Both PDP-2 (enkephalinase) and PDP-3 are apparently present in nerve terminal membranes predominantly as inactive proenzyme precursors, which elute from DEAE-cellulose at high salt concentration, and are activated very slowly by a process involving one or more trypsin-like enzymes. Rechromatography of activated PDP-2 and PDP-3 achieves a nearly complete separation of the two enzymes, both markedly purified, since each is much less acidic than its proenzyme precursor. Purified enkephalinase does not appear to have any significant
endopeptidase
activity. It cleaves Hip-Phe-Arg 200 times more effectively than Hip-Phe-Arg-
NH2
, and appears to be quite selective for cleaving the terminal dipeptide residue, Phe-Arg, from bradykinin, with no release of the second dipeptide and no cleavage of the Gly4-Phe5 interior peptide bond.
...
PMID:Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain. 631 70
The mode of action towards oligopeptides and proteins of hydrolase H purified from rabbit skeletal muscle was studied. The presence of protamine or alpha-N-benzoylarginine p-nitroanilide (an
endopeptidase
substrate) changed both the Km and V values of the enzyme towards Leu-beta-naphthylamide (an aminopeptidase substrate). This indicates that the binding site for an
endopeptidase
substrate is different from that for an aminopeptidase substrate. Hydrolase H as an aminopeptidase displayed broad specificity. The enzyme hydrolyzed various dipeptides readily except the dipeptides containing Pro or an amino acid with a hydrophobic beta-branched chain at the
NH2
terminus. Pro and Val at the
NH2
terminus of tripeptides were also difficult to release, whereas Ile and Val of tetrapeptides were easily released in contrast with those of dipeptides. The longer the peptide chain of Glyn (n = 2, 3, 4), the more susceptible was it to hydrolase H. Hydrolase H behaved as an
endopeptidase
only towards protamine among the proteins tested. The other proteins, casein, bovine serum albumin, myofibrils, troponin, hemoglobin, sarcoplasmic proteins, and myoglobin were probably attacked only by the aminopeptidase activity of the enzyme.
...
PMID:Mode of action towards oligopeptides and proteins of hydrolase H, a high-molecular-weight aminoendopeptidase from rabbit skeletal muscle. 636 Jun 85
In the present study we investigated the possible participation of endo-oligopeptidase B (poline-
endopeptidase
) in the control of gonadotrophin secretion through the control of LH-RH inactivation. This enzyme selectively hydrolyzes the Pro9-Gly10-
NH2
peptide bond of LH-RH, thereby inactivating this substance. The enzyme activity was evaluated using a specific colorimetric substrate, i.e., Z-Gly-Pro-SM. Female adult Wistar rats were submitted to castration, experimental situations that are known to produce changes in gonadotrophin secretion. Hypothalamic and pituitary endo-oligopeptidase B activity was shown to be present predominantly in the soluble fraction of the enzyme preparations. The results also indicated that endo-oligopeptidase B activity adult female rat pituitary decreased after castration and increased after administration of estradiol and progesterone to castrated animals. The present results lead us to suggest that anterior pituitary endo-oligopeptidase B may be related to the control gonadotrophin secretion in female rats.
...
PMID:Effect of gonadal steroids on hypothalamus and anterior pituitary endo-oligopeptidase B (proline-endopeptidase) activity in castrated female rats. 639 Mar 58
A
neutral endopeptidase
which degrades luteinizing hormone-releasing hormone (LH-RH, <GLu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-GLy-
NH2
) has been purified 900-fold from extracts of bovine anterior pituitary. This Ca2+-independent enzyme of 83 000 molecular weight (as estimated by gel filtration) cleaves LH-RH (KM = 180 microM) at the Tyr5-Gly6-His2-Trp3 bonds. Its activity is inhibited by the SH-reactive agents N-ethylmaleimide and p-(chloromercuri)benzoate but not by the OH-reactive agent diisopropyl fluorophosphate. Hydrolysis of the fluorogenic chymotrypsin substrate glutarkyl-Gly-Gly-Phe-beta-naphthylamide by this
endopeptidase
could not be detected. These properties differentiate the
endopeptidase
from chymotrypsin and from a glutaryl-Gly-Gly-Phe-beta-naphthylamide hydrolyzing activity of high molecular weight, which has been isolated from the same tissue and also hydrolyzes internal bonds of LH-RH.
...
PMID:Characterization of a nonchymotrypsin-like endopeptidase from anterior pituitary that hydrolyzes luteining hormone-releasing hormone at the tyrosyl-glycine and histidyl-tryptophan bonds. 699 98
Cleavage of parathyroid hormone (PTH) is catalyzed by an
endopeptidase
associated with a partially purified membrane preparation from bovine kidney cortex. This enzyme was found to have an acid pH optimum and to be easily extracted from the membranes by a single freeze-thaw cycle. The cleavage is remarkable in that it appears to be restricted to a small region of the PTH peptide chain, generating fragments which are not further degraded. The dominant products are a large fragment, COOH-terminal in origin, and a small fragment from the
NH2
terminus. The small fragment is biologically active and its activity establishes that it contains at least the first 29 amino acids in PTH. The large fragment has no biological activity. The cleavage of PTH was demonstrated both with iodinated PTH and with unlabeled hormone by immunoassay and by labeling the large fragment after its production. Microsequencing of the large fragment showed that, in fact, two products are produced: one with its
NH2
terminus at position 38 of PTH and one with its
NH2
terminus at position 35. These fragments are remarkably similar to those generated in both the liver and the kidney in vivo.
...
PMID:Specific cleavage of bovine parathyroid hormone catalyzed by an endopeptidase from bovine kidney. 702 35
The substrate specificity of a peptidase from anterior pituitaries that is capable of hydrolyzing luteinizing hormone-releasing hormone (LH-RH; less than Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-
NH2
) at the Tyr5-Gly6 peptide bond has been investigated by using inhibitors and model substrates. While trypsin and chymotrypsin inhibitors from plants and animals are without any effect, many microbial protease inhibitors and synthetic peptides containing hydrophobic and basic amino acids inhibit the degradation of radiolabeled LH-RH by this enzyme. The model substrates N-acetyl-Phe-Gly-Leu-beta-naphthylamide, N-acetyl-Leu-Gly-Leu-beta-naphthylamide, and N alpha-benzoyl-Arg-Gly-Leu-beta-naphthylamide are hydrolyzed at the X-Gly peptide bonds; N-acetyl-Gly-Gly-Leu-beta-naphthylamide is not degraded. Hydrolysis of typical amino- and carboxypeptidase substrates was not observed. Degradation of the general protease substrates insulin B chain and denatured hemoglobin also could not be detected. Thus, the enzyme is not LH-RH specific but may be characterized as an
endopeptidase
that hydrolyzes peptides preferentially at the carboxyl terminus of hydrophobic and basic amino acids.
...
PMID:Substrate specificity of an adenohypophyseal endopeptidase capable of hydrolyzing luteinizing hormone-releasing hormone: preferential cleavage of peptide bones involving the carboxyl terminus of hydrophobic and basic amino acids. 704 67
Parathyroid hormone (PTH) undergoes rapid proteolysis in the liver, which results in the appearance of multiple COOH-terminal fragments in plasma. Using reverse-phase high-performance liquid chromatographic (HPLC) techniques, we have shown that biologically active bovine PTH (bPTH) internally labeled with [3H]tyrosine is, like 125I-labeled bPTH, rapidly metabolized by isolated rat Kupffer cells in vitro to multiple COOH-terminal fragments that are chemically identical with those previously found in plasma after metabolism in vivo. Quantitation of specific carboxyl fragments in crude mixtures is achieved rapidly by direct HPLC analysis and is as precise as that achieved by Edman degradation. In addition, several different carboxyl fragments with identical
NH2
termini were resolved, revealing a complexity not apparent in previous studies employing direct Edman degradation of such mixtures. Parallel studies with [[35S]Met]bPTH show the generation, by the Kupffer cells in vitro, of several labeled
NH2
-terminal fragments which undergo rapid further degradation in vitro. Thus, hepatic metabolism of PTH by Kupffer cells proceeds by an initial
endopeptidase
cleavage within the hormonal sequence in a manner compatible with the generation of biologically active
NH2
fragments.
...
PMID:Metabolism of parathyroid hormone by Kupffer cells: analysis by reverse-phase high-performance liquid chromatography. 712 43
A multicatalytic proteinase complex present in the skin secretion of Xenopus laevis was purified and its enzymatic activity towards natural and synthetic peptides was investigated. We identified three activities: i) a C-terminal deamidation enzyme activity which exhibited selectivity for the Asp-Phe-
NH2
and Phe-Leu-
NH2
motifs of cerulein, minigastrin Leu-enkephalinamide, (des-Tyr1)Leu-enkephalinamide and diaminobenzylthiocyanate-DVDERDVRGFASFLNH2 (DABTC-DR8kermit); ii) an
endopeptidase
activity that cleaves peptide bonds on the carboxyl side of hydrophobic amino acid residues such as Tyr-Gly of LHRH, Ile-Ala of PGLa and Leu-Ala of buccalin; iii) an enzyme activity that cleaves peptide bonds at the dibasic sites of peptides of the dynorphin family. The molecular weight determined by Sephacryl S-400 molecular sieve filtration indicated an M(r) about 600 kDa. The activities characterized here exhibit an optimal pH of about 7.4. The activities of the multicatalytic complex were differentially inhibited by the classical inhibitors of proteases.
...
PMID:Isolation and properties of a multicatalytic proteinase complex from Xenopus laevis skin secretion. 755 6
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>